P746: Real-world Effectiveness and Safety of Advanced Combination Therapy in Patients with Inflammatory Bowel Disease: A Multi-center Brazilian Study.ECCO'24Year: 2024
Authors: Feitosa, F.C.(1);Queiroz, N.S.F.(2);Parra, R.S.(3);Azevedo, M.F.C.D.(4)*;Schiavetti , B.L.P.(5);Flores, C.(6);Fróes, R.D.S.B.(7);Boarini , L.R.(8);Boratto , S.D.F.(9);Junior, A.J.T.A.(10);Junior, N.L.T.G.(11);Nóbrega, F.J.F.(12);Teixeira, E.F.L.(13);Rzetelna, H.(14); Damião, A.O.M.C.(4);Motta , M.P.(15);Sassaki, L.Y.(16);Souza, H.S.P.D.(17);Luporini, R.L.(18);Ferreira , S.D.C.F.(19);Chebli, L.A.(20);Chebli, J.M.F.(20);
(1)Aliança Hospital- Rede d@E@Or São Luiz, Gastroenterology, Salvador, Brazil;(2)Health Sciences Graduate Program- Pontifícia Universidade Católica do Paraná PUCPR- Curitiba- Brazil 2. IBD outpatients clinic- Santa Cruz Hospital- Curitiba- Brazil, Gastroenterology, Curitiba, Brazil;(3)Ribeirão Preto Medical School University of São Paulo, Surgery, Ribeirão Preto, Brazil;(4)University of São Paulo School of Medicine, Gastroenterology, São Paulo, Brazil;(5)Inflammatory Bowel Diseases Outpatient Clinic, Gastroenterology, Santos, Brazil;(6)Inflammatory Bowel Disease Center, Gastroenterology, Porto Alegre, Brazil;(7)Department of Gastroenterology and Endoscopy- Gastromed, Gastroenterology, Rio de Janeiro, Brazil;(8)Inflammatory Bowel Disease Center- São Luiz São Caetano Hospital, Gastroenterology, São Caetano, Brazil;(9)Departament of General Surgery- Medical School- FMABC, Surgery, Santo André, Brazil;(10)Department of Surgery- Medical School- Pontificate Catholic University of Campinas PUC Campinas, Surgery, Campinas, Brazil;(11)Colonoscopy and colorectal Surgery Department of Inflammatory Bowel Diseases- Hospital Vivalle Rede DOr, Surgery, São José dos Campos, Brazil;(12)Department of Gastroenterology- Lauro Wanderley Hospital- Federal University of Paraíba, Gastroenterology, João Pessoa, Brazil;(13)Força Aérea do Galeão Hospital, Gastroenterology, Rio de Janeiro, Brazil;(14)1.General Hospital Santa Casa da Misericórdia do Rio de Janeiro/RJ 2. Departament Internal Medicine-Souza Marques Medicine School 3. University Estácio de Sá 4. Quinta D’Or Hospital, Gastroenterology, Rio de Janeiro, Brazil;(15)Hospital das Clínicas- Federal University of Bahia, Gastroenterology, Salvador, Brazil;(16)Department of Internal Medicine- Medical School- Sao Paulo State University UNESP, Internal Medicine, Botucatu, Brazil;(17)1. Department of Clinical Medicine- Federal University of Rio de Janeiro UFRJ 2. D’Or Institute for Research and Education IDOR, Clinical Medicine, Rio de Janeiro, Brazil;(18)1. Department of Medicine- Federal University of São Carlos- 2. Department of Surgery- Santa Casa of São Carlos- São Carlos, Medicine, São Carlos, Brazil;(19)Department of Clinical Medicine- Ribeirão Preto Medical School- University of São Paulo, Clinical Medicine, Ribeirão Preto, Brazil;(20)IBD Center- Federal University of Juiz de Fora, Gastroenterology, Juiz de Fora, Brazil;
P747: Assessment of a microlearning programme for patients with Inflammatory Bowel Disease (The ADEII project) on ansiety/depression status and illness perception.ECCO'24Year: 2024
Authors: De Castro Parga, M.L.(1,2)*;Hernández, V.(1,2);Sanromán, L.(1,2);Martínez-Cadilla, J.(1,2);Figueira, M.(1,2);Rodriguez-Prada, I.(1,2);
(1)Hospital Alvaro Cunqueiro CHUVI, Department of Gastroenterology, Vigo, Spain;(2)Galicia Sur Health Research Institute IIS Galicia Sur. SERGAS-UVIGO., Gastroenterology Research Group, Vigo, Spain;
P748: Place of thiopurine monotherapy in the treatment of Crohn@E@s Disease in the era of biologic therapies: results of a long-term tertiary single-center experienceECCO'24Year: 2024
Authors: Aouroud, H.(1)*;Aouroud, M.(1);Lairani, F.E.(1);Nacir, O.(1);Ait errami, A.(1);Oubaha, S.(1);Samlani, Z.(1);Krati, K.(1);
(1)Mohamed VI UNIVERSITY HOSPITAL, Gastro-enterology, Marrakech, Morocco;
P749: Comparison of bowel preparations for colonoscopy in inflammatory bowel disease- A systematic review and network meta-analysis of randomized trialsECCO'24Year: 2024
Authors: Chatterjee, A.(1);Kaur, S.(1);Jena, A.(2);Patil, A.(3);Dutta, U.(1);Sebastian, S.(4);Sharma, V.(5)*;
(1)PGIMER, Gastroenterology, Chandigarh, India;(2)SUM Hospital, Gastroenterology, Bhubhaneshwar, India;(3)PGIMER, Pharmacology, Chandigarh, India;(4)Hull University Teaching Hospitals NHS Trust, IBD Unit, Hull, United Kingdom;(5)Postgraduate Institute of Medical Education and Research, Gastroenterology, Chandigarh, India;
P750: Endoscopic balloon dilation associated with biological therapy in Crohn@E@s Disease strictures: a single center experience.ECCO'24Year: 2024
Authors: Lopetuso, L.R.(1);Coppola, G.(2)*;Alfieri, N.(1);Morretta, C.(1);Di Vincenzo, F.(1);Puca, P.(1);Parisio, L.(1);Marmo, C.(3);Settanni, C.R.(4);Laterza, L.(1);Pugliese, D.(1);Riccioni, M.E.(3);Cammarota, G.(5);Papa, A.(6);Gasbarrini, A.(5);Scaldaferri, F.(1);
(1)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, IBD Unit - CEMAD, Rome, Italy;(2)IRCSS Fondazione Policlinico Universitario A. Gemelli, IBD Unit - CEMAD, Rome, Italy;(3)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Endoscopia Digestiva Chirurgica, Rome, Italy;(4)IRCCS Istituto di Ricovero e Cura a Carattere Scientifico, UOSD Gastroenterologia ed Endoscopia Digestiva, Ancona, Italy;(5)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Internal Medicine and Gastroenterology, Rome, Italy;(6)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Day Hospital of Gastroenterology, Rome, Italy;
P751: Off-label dose escalation of Ustekinumab in Inflammatory Bowel Disease patients. Safety profil of different patterns.ECCO'24Year: 2024
Authors: García-Morales, N.(1,2);Agra-Blanco, I.(3);Gayoso-Rey, M.(3);Carmona, A.(4);Ayude, M.(1,5);De Castro Parga, M.L.(1,2)*;Rodriguez-Prada, I.(1,2);
(1)Hospital Alvaro Cunqueiro CHUVI, Department of Gastroenterology, Vigo, Spain;(2)Galicia Sur Health Research Institute IIS Galicia Sur. SERGAS-UVIGO., Gastroenterology Research Group, Vigo, Spain;(3)Hospital Alvaro Cunqueiro CHUVI, Department of Pharmacy, Vigo, Spain;(4)Hospital Ribera-POVISA, Department of Gastroenterology, Vigo, Spain;(5)Galicia Sur Health Research Institute IIS Galicia Sur. SERGAS-UVIGO., Department of Gastroenterology, Vigo, Spain;
P752: Difficult-to-treat inflammatory bowel disease: effectiveness and safety of 4th and 5th linesECCO'24Year: 2024
Authors: Caron, B.(1)*;Habert, A.(1);Bonsack, O.(1);Camara, H.(2);Jeanbert, E.(2);Parigi, T.L.(3);Netter, P.(4);Danese, S.(3);Peyrin-Biroulet, L.(1);
(1)Nancy University Hospital, Gastroenterology, Nancy, France;(2)Nancy University Hospital, Methodology- data management and statistic, Nancy, France;(3)IRCCS Ospedale San Raffaele, Gastroenterology and Endoscopy, Milan, Italy;(4)University of Lorraine, Ingénierie Moléculaire et Ingénierie Articulaire IMoPA- UMR-7365 CNRS, Vandoeuvre les Nancy, France;
P753: Early perianal abscess recurrence in patients with perianal Crohn@E@s disease on biologic therapy predicts long-term permanent fecal diversionECCO'24Year: 2024
Authors: Yokoo, T.(1)*;Yoshikawa, S.(1);Tsutomu, M.(1);Terauchi, S.(1);Uchida, H.(1);Nakao, T.(1);Yamaoka, K.(1);Inagaki, M.(1);Tani, T.(1);Okamoto, K.(1);Inatsugi, N.(1);
(1)Kenseikai Dongo hospital, Nara Coloproctology center, Yamatotakada city, Japan;
P754: Inadequate Pregnancy Specific Knowledge among Patients with Inflammatory Bowel Disease: A Multi-Center Survey in ChinaECCO'24Year: 2024
Authors: Li, R.(1)*;Wu, T.(2);Li, X.(1);Zhou, H.(1);Shi, Y.(3);Wang, F.(1);Liang, J.(4);
(1)Air Force Military Medical University, National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Xi@E@an, China;(2)Xijing Hospital of Digestive Diseases, State key Laboratory of Cancer Biology- National Clinical Research Center for Digestive Diseases, Xian, China;(3)Xijing Hospital of Digestive Diseases, State key Laboratory of Cancer Biology- National Clinical Research Center for Digestive Diseases, Xi@E@an, China;(4)Xijing Hospital of Digestive Diseases, State key Laboratory of Cancer Biology- National Clinical Research Center for Digestive Diseases and Xijing Hospital of Digestive Diseases, Xian, China;
P756: Efficacy and safety of medical therapies for maintenance of surgically induced remission in Crohn’s disease: A systematic review and network meta-analysisECCO'24Year: 2024
Authors: Sinopoulou, V.(1);Gordon, M.(1);Vuyyuru, S.(2)*;Darie, A.M.(3);Limdi, J.(4);Moran, G.(5);
(1)University of Central Lancashire, School of Medicine and Dentistry, Preston, United Kingdom;(2)Nottingham University Hospitals NHS trust, Gastroenterology, Nottingham, United Kingdom;(3)Nottingham University Hospitals NHS trust- Nottingham- UK, Gastroenterology, Nottingham, United Kingdom;(4)Northern Care Alliance NHS Foundation Trust- Manchester- UK, Department of Gastroenterology, Manchester, United Kingdom;(5)Nottingham University Hospitals NHS trust- Nottingham- UK- Nottingham NIHR Biomedical Research Centre- Nottingham- UK- Translational medical sciences- School of Medicine- Faculty of Medicine and Health science- University of Nottingham- UK, Gastroenterology, Nottingham, United Kingdom;
P757: Patient attitudes, perceptions, and beliefs on the role of diet and nutrition in inflammatory bowel diseases. A scoping review.ECCO'24Year: 2024
Authors: Magkiosi, A.(1);Strongylou, D.E.(2);Gkikas, K.(3);Gerasimidis, K.(3);Androutsos, O.(4);Svolos, V.(2,3)*;
(1)Laboratory of Hygiene- Social & Preventive Medicine and Medical Statistics, School of Medicine- Faculty of Health Sciences- Aristotle University of Thessaloniki, Thessaloniki, Greece;(2)Lab of Clinical Nutrition and Dietetics, Department of Nutrition and Dietetics- School of Physical Education- Sport Science and Dietetics- University of Thessaly, Trikala, Greece;(3)Human Nutrition- School of Medicine Dentistry & Nursing, College of Medical Veterinary and Life Sciences, Glasgow, United Kingdom;(4)Lab of Clinical Nutrition and Dietetics, School of Physical Education- Sport Science and Dietetics- University of Thessaly, Trikala, Greece;
P758: Effectiveness and tolerability of methotrexate monotherapy in Crohn’s disease patients: A multicenter observational studyECCO'24Year: 2024
Authors: Park, J.(1)*;Jaeyoung , C.(2);Soo Jung , P.(1);Jae Jun, P.(1);Tae Il , K.(1);Won Ho, K.(1);Hyuk , Y.(3);Jae Hee , C.(1);
(1)1Department of Internal Medicine- 2Institute of Gastroenterology- Severance Hospital- Yonsei University College of Medicine- Seoul- Korea, 1Department of Internal Medicine- 2Institute of Gastroenterology, Seoul, Korea- Republic Of;(2)3Department of Internal Medicine- Gangnam Severance Hospital- Yonsei University College of Medicine- Seoul- Korea, Department of Internal Medicine, Seoul, Korea- Republic Of;(3)4Department of Internal Medicine- Seoul National University Bundang Hospital- Seongnam- Korea, Department of Internal Medicine, Seoul, Korea- Republic Of;
P759: Understanding how patients with moderate-to-severe Crohn’s disease describe the spectrum of bowel urgency definitions: Results from qualitative researchECCO'24Year: 2024
Authors: Dubinsky, M.C.(1)*;Hunter Gibble, T.(2);Stassek, L.(3);Harding, G.(3);Stefan, M.(3);Fikre, T.(3);Potts Bleakman, A.(4);Moses, R.(4);
(1)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York City, United States;(2)Eli Lilly and Company, Value- Evidence- and Outcomes, Indianapolis, United States;(3)Evidera, Evidera, Bethesda, United States;(4)Eli Lilly and Company, Medical Affairs, Indianapolis, United States;
P760: Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: A final report of effectiveness and safety dataECCO'24Year: 2024
Authors: Matsuoka, K.(1)*;Motoya, S.(2);Yamamoto, T.(3);Matsuura, M.(4);Fujii, T.(5);Shinzaki, S.(6);Mikami, Y.(7);Arai, S.(8);Oshima, J.(9);Endo, Y.(9);Yuasa, H.(9);Hoshi, M.(8);Sato, K.(9);Hisamatsu, T.(4);
(1)Toho University Sakura Medical Center, Division of Gastroenterology and Hepatology- Department of Internal Medicine, Chiba, Japan;(2)Sapporo-Kosei General Hospital, Inflammatory Bowel Disease Center, Hokkaido, Japan;(3)Yokkaichi Hazu Medical Center, Department of Surgery and IBD Center, Yokkaichi Mie, Japan;(4)Kyorin University, Department of Gastroenterology and Hepatology, Mitaka Tokyo, Japan;(5)Tokyo Medical and Dental University, Department of Gastroenterology and Hepatology, Tokyo, Japan;(6)Hyogo Medical University, Division of Gastroenterology- Faculty of Medicine, Nishinomiya Hyogo, Japan;(7)Keio University School of Medicine, Division of Gastroenterology and Hepatology- Department of Internal Medicine, Tokyo, Japan;(8)-, Pfizer Japan Inc, Tokyo, Japan;(9)-, Pfizer R&D Japan, Tokyo, Japan;
P761: Clinical efficacy and durability of subcutaneous infliximab in patients with moderate-to-severe inflammatory bowel disease : a real-world data from a Korean multicentre prospective cohort studyECCO'24Year: 2024
Authors: Kim, K.(1)*;Hong, S.N.H.(2);Kang, S.B.K.(3);Lee, K.M.(4);Koo, J.S.K.(5);Jung , Y.(6);Lee, B.J.L.(7);Yoon, H.Y.(8);Kim, H.W.(9);Lim, Y.J.(10);Lee, H.S.(11);Lee, Y.J.(12);Lee , J.(13);Lee, C.K.(14);Moon, J.M.(15);Shin, S.Y.(16);Seo , J.(17);Choi , C.H.(17);
(1)Chung-Ang University Hospital, Department of gastroenterology, Seoul, Korea- Republic Of;(2)Samsung Medical Center- Sungkyunkwan University School of Medicine, Department of Medicine, Seoul, Korea- Republic Of;(3)Daejeon St. Mary’s Hospital- The Catholic University, Division of Gastroenterology- Department of Internal medicine, Daejeon St. Mary’s Hospital, Korea- Republic Of;(4)St. Vincent@E@s Hospital- College of Medicine- The Catholic University of Korea, Department of Internal Medicine, Suwon, Korea- Republic Of;(5)Korea University College of Medicine, Department of internal medicine, Ansan, Korea- Republic Of;(6)Soonchunhyang University College of Medicine, Department of Internal Medicine, Cheonan, Korea- Republic Of;(7)Korea University College of Medicine, Department of Internal Medicine, Seoul, Korea- Republic Of;(8)Seoul National University Bundang Hospital, Department of Internal Medicine, Seongnam, Korea- Republic Of;(9)Pusan National University Yangsan Hospital- Pusan National University College of Medicine, Department of Internal Medicine, Yangsan, Korea- Republic Of;(10)Dongguk University Ilsan Hospital, Department of Internal Medicine, Goyang, Korea- Republic Of;(11)Kyungpook National University School of Medicine, Department of Internal Medicine, Daegu, Korea- Republic Of;(12)Keimyung University School of Medicine-, Department of Internal Medicine, Daegu, Korea- Republic Of;(13)Chosun University College of Medicine, Department of Internal Medicine, Gwangju, Korea- Republic Of;(14)Kyung Hee University School of Medicine, Department of internal medicine, Seoul, Korea- Republic Of;(15)Chung-Ang University Gwangmyeong Hospital, Department of internal mediciine, Gwangmyeong, Korea- Republic Of;(16)Chung-Ang University Gwangmyeong Hospital, Internal medicine, Gwangmyeong, Korea- Republic Of;(17)Chung-Ang University Hospital, Internal medicine, Seoul, Korea- Republic Of;
P762: Risk of Infection After Acute Severe Ulcerative Colitis in East Asia and Australia/New Zealand: AOCC and ANZIBDC collaboration studyECCO'24Year: 2024
Authors: Kim, S.J.(1)*;Kim, D.H.(2,3);Park, S.H.(3,4);Kim, K.O.(3,5);Lee, Y.J.(3,6);Song, E.M.(3,7);Kim, E.S.(3,8);Lee, H.S.(8);An, Y.K.(9,10);Begun, J.(9,10);Ruddick-Collins, L.(10,11);Fernandes, R.(9);Liu, J.(12);Cao, Q.(12);Kobayashi, T.(13);Wei, S.C.(14);
(1)Chosun University Hospital, Division of Gastroenterology- Department of Internal Medicine, Gwangju, Korea- Republic Of;(2)Chonnam National University, Division of Gastroenterology- Department of Internal Medicine, Gwangju, Korea- Republic Of;(3)Korean Association for the Study of the Intestinal Diseases, IBD Research Group, Seoul, Korea- Republic Of;(4)University of Ulsan College of Medicine- Asan Medical Center, Department of Gastroenterology and Inflammatory Bowel Disease Center, Seoul, Korea- Republic Of;(5)Yeungnam University Hospital, Division of Gastroenterology- Department of Internal Medicine, Daegu, Korea- Republic Of;(6)Keimyung University Hospital, Division of Gastroenterology- Department of Internal Medicine, Daegu, Korea- Republic Of;(7)Ewha Womans University Seoul Hospital, Division of Gastroenterology- Department of Internal Medicine, Seoul, Korea- Republic Of;(8)Kyungpook National University Hospital, Division of Gastroenterology- Department of Internal Medicine, Daegu, Korea- Republic Of;(9)Mater Hospital, Department of Gastroenterology, Brisbane, Australia;(10)ANZIBDC, Australia New Zealand IBD Consortium, Brisbane, Australia;(11)University of Queensland, Mater Research Institute, Brisbane, Australia;(12)Zhejiang Chinese Medical University, School of Life Science, Hangzhou, China;(13)Kitasato University Kitasato Institute Hospital, Center for Advanced IBD Research and Treatment, Tokyo, Japan;(14)National Taiwan University Hospital- National Taiwan University, Department of Internal Medicine-, Taiwan, Taiwan;
P763: Rare and severe adverse events in pediatric inflammatory bowel disease: identification of safety signals through the international prospective PIBD-SETQuality Safety RegistryECCO'24Year: 2024
Authors: Klomberg, R.(1)*;Hellendoorn, A.(1);Kemos, C.(2);Rizopoulos, D.(3);Ruemmele, F.(4);Croft, N.(2);de Ridder, L.(1);
(1)Erasmus MC - Sophia Children@E@s Hospital, Paediatric Gastroenterology, Rotterdam, The Netherlands;(2)Barts and the London School of Medicine- Queen Mary University of London, Centre for Immunobiology- Blizard Institute, London, United Kingdom;(3)Erasmus Medical Center, Department of Epidemiology, Rotterdam, The Netherlands;(4)Université Paris Descartes- Sorbonne Paris Cité- APHP- Hôpital Necker Enfants Malades, Department of Pediatric Gastroenterology, Paris, France;PIBD-SETQuality Safety Registry collaborative group
P764: Darvastrocel in Treatment of 152 Patients with Perianal Crohn@E@s Disease - Observational StudyECCO'24Year: 2024
Authors: Serclova, Z.(1)*;Tremerova, A.(2);Ryska, O.(3);Zuskova, P.(4);Lengalova, M.(4);Vlkova, K.(5);
(1)Surgery, IBD Center Iscare- Surgical Departement- University Hospital- Kralovske Vinohrady- Prague, Praha 2 - Vinohrady, Czech Republic;(2)ISCARE, IBD centrum, Prague, Czech Republic;(3)Royal Lancaster Infirmary- UHMBT, Surgical, Lancaster, United Kingdom;(4)NH Hospital, Surgical, Horovice, Czech Republic;(5)ISCARE, IBD Center, Prague, Czech Republic;
P765: A Novel Monoclonal Antibody Drug Candidate SPY001 Targeting Integrin ɑ4β7 for the Treatment of IBD Demonstrates Prolonged Half-Life in Non-Human PrimatesECCO'24Year: 2024
Authors: Zhu, E.(1);Rios, D.(2);Vaz, R.(3);Friedman, J.(4)*;Nguyen, D.(5);Spencer, A.(6);Oh, J.(2);Shaheen, H.(7);
(1)Paragon Therapeutics, Biotherapeutics Discovery, Waltham- MA, United States;(2)Paragon Therapeutics, Biology, Waltham- MA, United States;(3)Paragon Therapeutics, Program and Alliance Management, Waltham- MA, United States;(4)Spyre Therapeutics, Clinical Development, Ardmore, United States;(5)Spyre Therapeutics, Clinical Development, Waltham- MA, United States;(6)Spyre Therapeutics, Nonclinical Development, Waltham- MA, United States;(7)Paragon Therapeutics, Research, Waltham- MA, United States;
